4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-014878
Chief Executive Officer sold 72,995 shares at $9.46 ($690,365)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Backer Marianne Chief Executive Officer | 2024-04-03 | Sale 10b5-1 | −72,995 | $9.46 | $690,365 | 678,457 | D |
| Open-market sales · 72,995 sh · avg $9.46 · $690,365 | |||||||
Loading xslF345X05/wk-form4_1712261678.xml…